BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 27, 2009
View Archived Issues
DSMB recommends continuation of Stem Cell Therapeutics' phase IIb stroke trial of NTx-265
Read More
Cara Therapeutics describes novel CB2 receptor agonists for the treatment of pain
Read More
Genentech and Array BioPharma present Raf kinase inhibitors for cancer treatment
Read More
Nurr-1 receptor ligands disclosed by sanofi-aventis for the treatment of epilepsy
Read More
Novel histamine H3 receptor antagonists in development at Evotec Neurosciences
Read More
Novartis describes CXCR2 receptor antagonists for the treatment of COPD
Read More
Merck & Co. claims novel hypoxia-inducible factor prolyl hydroxylase inhibitors
Read More
CAL-120, with potent in vivo antitumor activity, selected for clinical evaluation
Read More
Once-daily mesalazine is as effective as twice-daily dosing in UC remission maintenance
Read More
Ondansetron confers no significant improvement in emesis in children with acute gastroenteritis
Read More
Promising phase II data on AZD-0837 support further evaluation in AF patients
Read More
Lundbeck reports results from third quarter of 2009
Read More
GW Pharmaceuticals completes recruitment in phase II/III trial of Sativex in cancer pain
Read More
EMEA grants orphan drug status to LFB Biotechnologies' LFB-R603 antibody for CLL
Read More
Novartis and Incyte sign exclusive license agreement for INCB-18424 and INCB-28060
Read More
AEterna reports results of phase II trial of AEZS-108 in endometrial cancer
Read More
Biovitrum completes phase II clinical study of Kiobrina in preterm infants
Read More
Aflibercept shows promise in phase II trial in metastatic melanoma patients
Read More
Ohr presents update on clinical development of OHR/AVR-118 for cachexia
Read More
Genfit reports results from phase II trial of GFT-505 in fatty liver diseases
Read More
IWT awards grant to Ablynx for development of Nanobodies
Read More
DNDi receives grant from Bill and Melinda Gates Foundation to develop fexinidazole for HAT
Read More
Cleveland BioLabs initiates enrollment in safety study of CBLB-502 for ARS
Read More
University of Minnesota and Celladon develop technology for screening drugs in heart failure
Read More
FDA grants traditional approval to Tibotec's NNRTI drug Intelence
Read More
Merck & Co. to initiate phase IIa clinical trial of MK-6913 for vasomotor symptoms
Read More
University of Navarra initiates clinical trial of personalized vaccines for glioblastoma
Read More